The role of CD95 system in chemotherapy
- 30 April 1999
- journal article
- Published by Elsevier in Drug Resistance Updates
- Vol. 2 (2) , 85-90
- https://doi.org/10.1054/drup.1999.0073
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Mitochondria and ApoptosisScience, 1998
- Requirement for the CD95 Receptor-Ligand Pathway in c-Myc-Induced ApoptosisScience, 1997
- Apoptosis by Death FactorCell, 1997
- Fas/APO‐1 (CD95)‐mediated cytotoxicity is responsible for the apoptotic cell death of leukaemic cells induced by interleukin‐2‐activated T cellsBritish Journal of Haematology, 1997
- Expression of Fas antigen in acute myeloid leukaemia is associated with therapeutic response to chemotherapyBritish Journal of Haematology, 1996
- Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signalsCell, 1995
- Mutations in Fas Associated with Human Lymphoproliferative Syndrome and AutoimmunityScience, 1995
- Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)Nature, 1995
- The Role of APO‐1‐Mediated Apoptosis in the Immune SystemImmunological Reviews, 1994
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994